| Rapid molecular detection of tuberculosis and rifampin resistance CC Boehme, P Nabeta, D Hillemann, MP Nicol, S Shenai, F Krapp, ... New England Journal of Medicine 363 (11), 1005-1015, 2010 | 3207 | 2010 |
| The diarylquinoline TMC207 for multidrug-resistant tuberculosis AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ... New England Journal of Medicine 360 (23), 2397-2405, 2009 | 1096 | 2009 |
| A four-month gatifloxacin-containing regimen for treating tuberculosis CS Merle, K Fielding, OB Sow, M Gninafon, MB Lo, T Mthiyane, ... New England Journal of Medicine 371 (17), 1588-1598, 2014 | 510 | 2014 |
| What we know about tuberculosis transmission: an overview G Churchyard, P Kim, NS Shah, R Rustomjee, N Gandhi, B Mathema, ... The Journal of infectious diseases 216 (suppl_6), S629-S635, 2017 | 470 | 2017 |
| A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis R Rustomjee, C Lienhardt, T Kanyok, GR Davies, J Levin, T Mthiyane, ... The international journal of tuberculosis and lung disease 12 (2), 128-138, 2008 | 447 | 2008 |
| Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ... Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008 | 395 | 2008 |
| Host-directed therapies for infectious diseases: current status, recent progress, and future prospects A Zumla, M Rao, RS Wallis, SHE Kaufmann, R Rustomjee, P Mwaba, ... The Lancet Infectious Diseases 16 (4), e47-e63, 2016 | 338 | 2016 |
| Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ... The Lancet infectious diseases 16 (4), e34-e46, 2016 | 322 | 2016 |
| Drivers of tuberculosis transmission B Mathema, JR Andrews, T Cohen, MW Borgdorff, M Behr, JR Glynn, ... The Journal of infectious diseases 216 (suppl_6), S644-S653, 2017 | 232 | 2017 |
| Treatment of tuberculosis: present status and future prospects P Onyebujoh, A Zumla, I Ribeiro, R Rustomjee, P Mwaba, M Gomes, ... Bulletin of the World Health Organization 83, 857-865, 2005 | 145 | 2005 |
| The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis FA Sirgel, PB Fourie, PR Donald, N Padayatchi, R Rustomjee, J Levin, ... American journal of respiratory and critical care medicine 172 (1), 128-135, 2005 | 143 | 2005 |
| Towards host-directed therapies for tuberculosis A Zumla, J Chakaya, M Hoelscher, F Ntoumi, R Rustomjee, C Vilaplana, ... Nature reviews Drug discovery 14 (8), 511-512, 2015 | 137 | 2015 |
| Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective … SG Mfinanga, BJ Kirenga, DM Chanda, B Mutayoba, T Mthiyane, G Yimer, ... The Lancet infectious diseases 14 (7), 563-571, 2014 | 136 | 2014 |
| Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis C Riou, B Perez Peixoto, L Roberts, K Ronacher, G Walzl, C Manca, ... PloS one 7 (5), e36886, 2012 | 124 | 2012 |
| Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines H McIlleron, R Rustomjee, M Vahedi, T Mthiyane, P Denti, C Connolly, ... Antimicrobial agents and chemotherapy 56 (6), 3232-3238, 2012 | 123 | 2012 |
| A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients W Smythe, A Khandelwal, C Merle, R Rustomjee, M Gninafon, M Bocar Lo, ... Antimicrobial agents and chemotherapy 56 (4), 2091-2098, 2012 | 112 | 2012 |
| Model-based evaluation of higher doses of rifampin using a semimechanistic model incorporating autoinduction and saturation of hepatic extraction MT Chirehwa, R Rustomjee, T Mthiyane, P Onyebujoh, P Smith, ... Antimicrobial agents and chemotherapy 60 (1), 487-494, 2016 | 89 | 2016 |
| Transmission of drug-resistant tuberculosis in HIV-endemic settings PY Khan, TA Yates, M Osman, RM Warren, Y van der Heijden, ... The Lancet Infectious Diseases 19 (3), e77-e88, 2019 | 86 | 2019 |
| Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational … TH Holtz, G Kabera, T Mthiyane, T Zingoni, S Nadesan, D Ross, J Allen, ... The Lancet infectious diseases 11 (7), 533-540, 2011 | 84 | 2011 |
| A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting R Rustomjee, ABM Kharsany, CA Connolly, SSA Karim Journal of Antimicrobial Chemotherapy 49 (5), 875-878, 2002 | 71 | 2002 |
